The optogenetic promise for oncology: Episode I

Alvaro Ingles-Prieto; Eva Gschaider-Reichhart; Karin Schelch; Harald Janovjak; Michael Grusch

doi:10.4161/23723548.2014.964045

The optogenetic promise for oncology: Episode I

Alvaro Ingles-Prieto, Eva Gschaider-Reichhart, Karin Schelch, Harald Janovjak, Michael Grusch

Research output: Contribution to journal › Article › Other › peer-review

4 Citations (Scopus)

Abstract

As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression.

Original language	English
Article number	e964045-1
Number of pages	3
Journal	Molecular and Cellular Oncology
Volume	1
Issue number	4
DOIs	https://doi.org/10.4161/23723548.2014.964045
Publication status	Published - 29 Oct 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4161/23723548.2014.964045

242348334-oaFinal published version, 212 KB

Cite this

@article{dc272206c07d4c1a856fc4be17a804c3,

title = "The optogenetic promise for oncology: Episode I",

abstract = "As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression.",

author = "Alvaro Ingles-Prieto and Eva Gschaider-Reichhart and Karin Schelch and Harald Janovjak and Michael Grusch",

year = "2014",

month = oct,

day = "29",

doi = "10.4161/23723548.2014.964045",

language = "English",

volume = "1",

journal = "Molecular and Cellular Oncology",

issn = "2372-3556",

publisher = "Taylor & Francis",

number = "4",

}

TY - JOUR

T1 - The optogenetic promise for oncology

T2 - Episode I

AU - Ingles-Prieto, Alvaro

AU - Gschaider-Reichhart, Eva

AU - Schelch, Karin

AU - Janovjak, Harald

AU - Grusch, Michael

PY - 2014/10/29

Y1 - 2014/10/29

N2 - As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression.

AB - As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression.

U2 - 10.4161/23723548.2014.964045

DO - 10.4161/23723548.2014.964045

M3 - Article

SN - 2372-3556

VL - 1

JO - Molecular and Cellular Oncology

JF - Molecular and Cellular Oncology

IS - 4

M1 - e964045-1

ER -